Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Watson Confirms Court Decision Rejecting Teva's Motion to Prevent Launch of Generic SEASONIQUE®
June 17, 2011
from PR Newswire
Watson's Nabumetone Tablets Receive FDA Approval
June 17, 2011
from PR Newswire
Watson Confirms Pataday™ Patent Challenge
June 14, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson's Generic Lybrel® Receives FDA Approval
June 07, 2011
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Pharmaceuticals Future Continues to Look Bright
June 03, 2011
from Marketwired News Releases
Watson Confirms Viagra® Patent Challenge
June 02, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
June 01, 2011
from PR Newswire
Watson Acquires Specifar Pharmaceuticals
May 25, 2011
- Adds Leading Pan-European Generic Development Business Read More
from PR Newswire
Watson Pharmaceuticals Announces New Research Showing RAPAFLO(R) (silodosin) Improves Outcomes for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
May 17, 2011
- Treatment Reduces Symptoms and Improves Quality of Life - Read More
from PR Newswire
Watson Launches Generic AMRIX®
May 16, 2011
from PR Newswire
Columbia Laboratories Reports First Quarter 2011 Financial Results
May 05, 2011
from Business Wire News Releases
Watson Launches Generic Concerta®
May 02, 2011
from PR Newswire
Watson's Generess™ Fe, Unique, Low-Dose Oral Contraceptive Launched
May 02, 2011
- "I am Generess™" Companion Program Features Patient Cost Savings, Women's Charity Donation - Read More
from PR Newswire
Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 13th
April 29, 2011
from PR Newswire
Watson First Quarter 2011 Net Revenue Increases to $877 Million
April 27, 2011
- First Quarter 2011 Non-GAAP EPS up 10% to $0.89 - Read More
from PR Newswire
Columbia Laboratories Submits NDA for PROCHIEVE® Vaginal Progesterone Gel
April 26, 2011
from PR Newswire
Nathan Cummings Foundation and ACGI Contribute to Board Declassification in Seven S&P 500 Companies
April 26, 2011
from Business Wire News Releases
Watson Confirms Welchol® Patent Challenge
April 20, 2011
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Pharmaceutical-Biotech Industry Kicks Off Spring With a Roar: $4.5 Billion Investment in 2Q11 Project Starts More Than Double 2Q10, an Industrial Info News Alert
April 19, 2011
from Marketwired News Releases
Critical Alerts for Goldman Sachs, Merck, Expedia, Yamana Gold, and Watson Pharmaceuticals Released by Seven Summits Research
April 15, 2011
from PR Newswire
Watson Designates Parsippany, NJ Facility as Corporate Headquarters
April 13, 2011
- New Parsippany Facility Supports Global Expansion; Unites NJ Operations in Single Location - Read More
from PR Newswire
Stellar Pharmaceuticals Inc. and Watson Pharmaceuticals, Inc. Terminate Uracyst(R) Supply and Licensing Agreements
April 13, 2011
from Marketwired News Releases
Watson Confirms Vigamox® Patent Challenge
April 08, 2011
- Paragraph IV Litigation Underway- Read More
from PR Newswire
Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
April 06, 2011
Data Demonstrate a Significantly Lower Rate of Preterm Birth before 33 Weeks Gestation among Women with a Shortened Cervix treated with PROCHIEVE vs. Placebo Read More
from PR Newswire
Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
April 06, 2011
- Data Demonstrate a Significantly Lower Rate of Preterm Birth before 33 Weeks Gestation among Women with a Shortened Cervix treated with PROCHIEVE vs. Placebo - Read More
from PR Newswire
Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
April 05, 2011
from PR Newswire
Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
March 31, 2011
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. -- Generic Drug Makers Benefit From Expiring Rights and Expanding Medicaid Coverage
March 30, 2011
from Marketwired News Releases
Columbia Laboratories' Provides Update on PREGNANT Study Publication
March 30, 2011
from Business Wire News Releases
Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
March 25, 2011
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here